tradingkey.logo

Nanobiotix SA

NBTX
查看詳細走勢圖
20.850USD
-0.190-0.90%
收盤 02/06, 16:00美東報價延遲15分鐘
1.01B總市值
虧損本益比TTM

Nanobiotix SA

20.850
-0.190-0.90%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-0.90%

5天

-0.71%

1月

-2.93%

6月

+189.99%

今年開始到現在

-9.82%

1年

+426.52%

查看詳細走勢圖

TradingKey 股票評分

由於缺少必要的數據,暫時無法對該公司進行評分

Nanobiotix SA新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Nanobiotix SA簡介

Nanobiotix SA is a France-based nanomedicine company. The Company designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. It develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The Company's NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) provides potential cure and gives the systemic treatment a better chance to life expectancy. NanoXray products are developed for the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.
公司代碼NBTX
公司Nanobiotix SA
CEOLevy (Laurent)
網址https://www.nanobiotix.com
KeyAI